View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Obinutuzumab 1000 / Zanubrutinib 160 / Venetoclax (20/50/100/200/400), Mantle Cell Lymphoma, Cycle 3
Protocol-ID: 2767 V1.0 (Mini), OBIN1000/ZANU160/VNTC(20/50/100/200/400), MCL, C3Indication(s)
- Mantle Cell Lymphoma (TP53 mutation); ICD-10 C83.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.12.2024